Icecure Medical
Price
Price
Frequently asked questions
What is Icecure Medical's market capitalization?
What is the Earnings Per Share (EPS) for Icecure Medical?
What are the analyst ratings and target price for Icecure Medical's stock?
What is Icecure Medical's revenue over the trailing twelve months?
What is the EBITDA for Icecure Medical?
What is the free cash flow of Icecure Medical?
What is the 5-year beta of Icecure Medical's stock?
How many employees does Icecure Medical have, and what sector and industry does it belong to?
What is the free float of Icecure Medical's shares?
Financials
Market Cap
$35.27M5Y beta
2.53EPS (TTM)
-$0.293Free Float
22.69MRevenue (TTM)
$3.34MEBITDA (TTM)
-$14.08MFree Cashflow (TTM)
-$11.02MPricing
Analyst Ratings
The price target is $3.328 and the stock is covered by 4 analysts.
Buy
4
Hold
0
Sell
0
Information
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
71
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker